CGON
CG Oncology, Inc. Common stock
NASDAQ: CGON · HEALTHCARE · BIOTECHNOLOGY
$66.74
+3.07% today
Updated 2026-04-30
Market cap
$5.70B
P/E ratio
—
P/S ratio
1,410.56x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$21 – $74
Volume
1.3M
CG Oncology, Inc. Common stock (CGON) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $58.69M | $147.75M | $199.30M | $754.80M |
| Cash & equivalents | — | — | — | — |
| Current assets | $58.41M | $147.21M | $194.12M | $754.21M |
| Total liabilities | $18.44M | $22.57M | $14.51M | $21.42M |
| Current liabilities | $5.97M | $15.43M | $14.25M | $21.37M |
| Long-term debt | $12.06M | $6.53M | — | — |
| Shareholder equity | — | — | — | — |
| Retained earnings | $-45.89M | $-81.33M | $-129.94M | $-217.98M |
| Accounts receivable | $2000.00 | $303000.00 | $92000.00 | $781000.00 |
| Inventory | — | — | — | — |
| Goodwill | — | — | — | — |